Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Authors
Keywords
-
Journal
npj Vaccines
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-21
DOI
10.1038/s41541-022-00436-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice
- (2021) Juan García-Arriaza et al. JOURNAL OF VIROLOGY
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
- (2021) Nanda Kishore Routhu et al. IMMUNITY
- SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
- (2021) John P. Moore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
- (2021) Ruikang Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Correlates of protection from SARS-CoV-2 infection
- (2021) Florian Krammer LANCET
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
- (2021) Paul E. Harris et al. Vaccines
- Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
- (2021) William E. Matchett et al. JOURNAL OF IMMUNOLOGY
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
- (2021) Alina Tscherne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
- (2021) Tanushree Dangi et al. Cell Reports
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
- (2021) Raj Kalkeri et al. Microorganisms
- Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients
- (2020) Ibrahim Aldoss et al. ANNALS OF INTERNAL MEDICINE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
- (2020) Till Koch et al. LANCET INFECTIOUS DISEASES
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
- (2020) Vincent J. Munster et al. NATURE
- SARS-CoV-2 infection protects against rechallenge in rhesus macaques
- (2020) Abishek Chandrashekar et al. SCIENCE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- (2020) Noton K. Dutta et al. JOURNAL OF VIROLOGY
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
- (2020) Lisa H. Tostanoski et al. NATURE MEDICINE
- Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
- (2020) Robert W. Cross et al. Virology Journal
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
- (2020) Lorena Sanchez-Felipe et al. NATURE
- Establishment of an African green monkey model for COVID-19 and protection against re-infection
- (2020) Courtney Woolsey et al. NATURE IMMUNOLOGY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct visualization of translational GTPase factor pool formed around the archaeal ribosomal P-stalk by high-speed AFM
- (2020) Hirotatsu Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
- (2020) Flavia Chiuppesi et al. Nature Communications
- Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
- (2019) Phillip R. Pittman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice
- (2018) Flavia Chiuppesi et al. JOURNAL OF VIROLOGY
- Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab
- (2017) Yuan Yuan et al. OncoImmunology
- MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults
- (2016) Corinna La Rosa et al. BLOOD
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex
- (2014) Felix Wussow et al. PLoS Pathogens
- Clinical development of Modified Vaccinia virus Ankara vaccines
- (2013) Sarah C. Gilbert VACCINE
- A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques
- (2012) Felix Wussow et al. JOURNAL OF VIROLOGY
- Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells
- (2009) Stephan Halle et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More